These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25953442)

  • 1. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of transcription profiling of solid pseudopapillary neoplasm of the pancreas.
    Zhang Y; Han X; Wu H; Zhou Y
    Mol Med Rep; 2017 Aug; 16(2):1635-1642. PubMed ID: 28627654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying endometriosis pathogenesis revealed by bioinformatics analysis of microarray data.
    Ping S; Ma C; Liu P; Yang L; Yang X; Wu Q; Zhao X; Gong B
    Arch Gynecol Obstet; 2016 Apr; 293(4):797-804. PubMed ID: 26354330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting of disease genes for gestational diabetes mellitus based on network and functional consistency.
    Zhang Q; He M; Wang J; Liu S; Cheng H; Cheng Y
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():91-6. PubMed ID: 25666344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile analysis of new candidate genes for the therapy of primary osteoporosis.
    Zhang Y; Wang N; Ma J; Chen XC; Li Z; Zhao W
    Eur Rev Med Pharmacol Sci; 2016; 20(3):433-40. PubMed ID: 26914116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
    Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
    Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of potential targets and small-molecule drugs related to lipid metabolism in ovarian cancer based on bioinformatics.
    Wang X; Zhu L; Deng Y; Zhang Q; Li R; Yang L
    Biochem Biophys Res Commun; 2024 Nov; 733():150673. PubMed ID: 39293329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
    Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
    Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D; Tian H
    World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.